Skip to content
10-K

Annual Report

PAVmed Inc. PAVM

0001437749-26-010115

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 27, 2026 6.38M sh
Shares Diluted FY 2025 · Dec 31, 2025 670.47K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 2.17M sh
Capex FY 2025 · Dec 31, 2025 $31K
Capex FY 2025 · Dec 31, 2024 $55K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$5.21M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$33.55M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.54M
Cash And Equivalents FY 2025 · Dec 31, 2024 $1.19M
Stockholders Equity FY 2025 · Dec 31, 2025 $33.97M
Stockholders Equity FY 2025 · Dec 31, 2024 −$2.5M
Current Liabilities FY 2025 · Dec 31, 2025 $14.84M
Current Liabilities FY 2025 · Dec 31, 2024 $35.45M
Total Liabilities FY 2025 · Dec 31, 2025 $16.51M
Total Liabilities FY 2025 · Dec 31, 2024 $37.69M
Current Assets FY 2025 · Dec 31, 2025 $2.56M
Current Assets FY 2025 · Dec 31, 2024 $2.16M
Total Assets FY 2025 · Dec 31, 2025 $38.81M
Total Assets FY 2025 · Dec 31, 2024 $30.66M
Eps Diluted FY 2025 · Dec 31, 2025 −$5.63
Eps Diluted restated FY 2025 · Dec 31, 2024 $14.90
Eps Basic FY 2025 · Dec 31, 2025 −$5.63
Eps Basic restated FY 2025 · Dec 31, 2024 $99.15
Sga Expense FY 2025 · Dec 31, 2025 $16.25M
Sga Expense FY 2025 · Dec 31, 2024 $24.52M
Rd Expense FY 2025 · Dec 31, 2025 $4.49M
Rd Expense FY 2025 · Dec 31, 2024 $5.93M
Net Income FY 2025 · Dec 31, 2025 $401K
Net Income FY 2025 · Dec 31, 2024 $39.79M
Operating Income FY 2025 · Dec 31, 2025 −$21.81M
Operating Income FY 2025 · Dec 31, 2024 −$44.49M
Cost Of Revenue FY 2025 · Dec 31, 2025 $218K
Cost Of Revenue FY 2025 · Dec 31, 2024 $4.84M
Revenue FY 2025 · Dec 31, 2025 $71K
Revenue FY 2025 · Dec 31, 2024 $3M